Pigmentation & Melanogenesis
Transcriptomic Biomarkers Analysis
Pigmentation and Melanogenesis Analysis – Transcriptomic Biomarkers
Skin pigmentation and the melanogenesis process are regulated by a series of complex biological mechanisms involving specific genes. Gene expression analysis helps identify biomarkers associated with melanin production, skin pigmentation variations, and pigmentary disorders.
Genes Analyzed in Pigmentation and Melanogenesis
Our panel targets key biomarkers associated with melanin production, pigmentation regulation, and response to environmental factors, including:
MC1R (Melanocortin 1 Receptor) – A key receptor in melanogenesis, involved in melanin production and UV response
TYR (Tyrosinase) – An essential enzyme in melanin synthesis, crucial for skin pigmentation
TYRP1 (Tyrosinase-Related Protein 1) – An enzyme involved in melanin production, linked to skin color regulatio
MITF (Microphthalmia-Associated Transcription Factor) – A transcription factor regulating melanocyte differentiation and melanin production
SLC45A2 (Solute Carrier Family 45 Member 2) – A protein transporter involved in skin pigmentation regulation
ASIP (Agouti Signaling Protein) – A protein that inhibits melanin production and influences skin and hair color
OCA2 (Oculocutaneous Albinism II) – A gene responsible for skin and hair pigmentation, implicated in albinism
MC2R (Melanocortin 2 Receptor) – A receptor involved in corticosteroid production and pigmentation regulation
GPR143 (G Protein-Coupled Receptor 143) – A receptor associated with pigmentation disorders, including albinism
KITLG (Kit Ligand) – A protein involved in melanocyte development and skin pigmentation regulation
Applications & Benefits
Understanding pigmentation mechanisms: Biomarker analysis enhances knowledge of skin pigmentation biology and response to environmental factors such as sun exposure
Evaluating pigmentary disorders: Identifying genetic and biological causes of pigmentation disorders like vitiligo, albinism, and age spots
Personalizing dermatological treatments: Optimizing treatments for pigmentation disorders based on genes involved in melanogenesis
Monitoring UV exposure effects: Assessing the impact of sun and UV exposure on pigmentation-related gene expression
Preventing skin cancer: Identifying biomarkers that predict susceptibility to pigmentation spots or UV-related skin cancers
Technologies Used
We use advanced technologies for precise biomarker analysis in pigmentation and melanogenesis:
RT-qPCR and RNA-seq (NGS) to quantify gene expression related to melanin production and pigmentation
Immunohistochemistry to measure protein expression in melanocytes and skin pigmentation
Multiplexed technologies (e.g., Nanostring) for simultaneous biomarker analysis of pigmentation and pigmentary disorders
Clinical tests to evaluate treatment effects on melanogenesis gene expression and pigmentation
Contact us at contact@genxmap.com for a personalized analysis of skin pigmentation and melanogenesis to optimize your dermatological approach and prevent pigmentation disorders!




